341 related articles for article (PubMed ID: 18029187)
1. Synthesis and structure-activity relationships of N-(3-phenylpropyl)-N'-benzylpiperazines: Potent ligands for sigma1 and sigma2 receptors.
Nahas RI; Lever JR; Lever SZ
Bioorg Med Chem; 2008 Jan; 16(2):755-61. PubMed ID: 18029187
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands.
Moussa IA; Banister SD; Beinat C; Giboureau N; Reynolds AJ; Kassiou M
J Med Chem; 2010 Aug; 53(16):6228-39. PubMed ID: 20662542
[TBL] [Abstract][Full Text] [Related]
3. Characterization of novel N,N'-disubstituted piperazines as sigma receptor ligands.
Zhang Y; Williams W; Torrence-Campbell C; Bowen WD; Rice KC
J Med Chem; 1998 Dec; 41(25):4950-7. PubMed ID: 9836612
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of bridged piperazines with sigma receptor affinity.
Weigl M; Wünsch B
Eur J Med Chem; 2007 Oct; 42(10):1247-62. PubMed ID: 17420073
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies.
Matsumoto RR; Potelleret FH; Mack A; Pouw B; Zhang Y; Bowen WD
Pharmacol Biochem Behav; 2004 Apr; 77(4):775-81. PubMed ID: 15099923
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands.
Costantino L; Gandolfi F; Sorbi C; Franchini S; Prezzavento O; Vittorio F; Ronsisvalle G; Leonardi A; Poggesi E; Brasili L
J Med Chem; 2005 Jan; 48(1):266-73. PubMed ID: 15634021
[TBL] [Abstract][Full Text] [Related]
8. Chiral, nonracemic (piperazin-2-yl)methanol derivatives with sigma-receptor affinity.
Bedürftig S; Wünsch B
Bioorg Med Chem; 2004 Jun; 12(12):3299-311. PubMed ID: 15158798
[TBL] [Abstract][Full Text] [Related]
9. Effects of linker elongation in a series of N-(2-benzofuranylmethyl)-N'-(methoxyphenylalkyl)piperazine σ₁ receptor ligands.
Moussa IA; Banister SD; Akladios FN; Chua SW; Kassiou M
Bioorg Med Chem Lett; 2011 Oct; 21(19):5707-10. PubMed ID: 21871797
[TBL] [Abstract][Full Text] [Related]
10. N-[omega-(Tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine are highly potent and selective sigma1 or sigma2 ligands.
Berardi F; Santoro S; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1998 Oct; 41(21):3940-7. PubMed ID: 9767631
[TBL] [Abstract][Full Text] [Related]
11. Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).
Berardi F; Abate C; Ferorelli S; Uricchio V; Colabufo NA; Niso M; Perrone R
J Med Chem; 2009 Dec; 52(23):7817-28. PubMed ID: 19842660
[TBL] [Abstract][Full Text] [Related]
12. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.
Zampieri D; Grazia Mamolo M; Laurini E; Zanette C; Florio C; Collina S; Rossi D; Azzolina O; Vio L
Eur J Med Chem; 2009 Jan; 44(1):124-30. PubMed ID: 18440098
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands.
Vangveravong S; Xu J; Zeng C; Mach RH
Bioorg Med Chem; 2006 Oct; 14(20):6988-97. PubMed ID: 16837201
[TBL] [Abstract][Full Text] [Related]
14. Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity.
Mésangeau C; Narayanan S; Green AM; Shaikh J; Kaushal N; Viard E; Xu YT; Fishback JA; Poupaert JH; Matsumoto RR; McCurdy CR
J Med Chem; 2008 Mar; 51(5):1482-6. PubMed ID: 18278854
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-affinity relationships of novel spirocyclic sigma receptor ligands with furopyrazole structure.
Schläger T; Schepmann D; Würthwein EU; Wünsch B
Bioorg Med Chem; 2008 Mar; 16(6):2992-3001. PubMed ID: 18221879
[TBL] [Abstract][Full Text] [Related]
16. (+)-cis-N-ethyleneamino-N-normetazocine derivatives. Novel and selective sigma ligands with antagonist properties.
Ronsisvalle G; Marrazzo A; Prezzavento O; Pasquinucci L; Vittorio F; Pittalà V; Pappalardo MS; Cacciaguerra S; Spampinato S
J Med Chem; 1998 May; 41(10):1574-80. PubMed ID: 9572883
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of naphthol- and carbazole-containing fluorescent sigma ligands as potential probes for receptor binding studies.
Ferorelli S; Abate C; Colabufo NA; Niso M; Inglese C; Berardi F; Perrone R
J Med Chem; 2007 Sep; 50(19):4648-55. PubMed ID: 17713896
[TBL] [Abstract][Full Text] [Related]
18. Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice.
Sage AS; Oelrichs CE; Davis DC; Fan KH; Nahas RI; Lever SZ; Lever JR; Miller DK
Pharmacol Biochem Behav; 2013 Sep; 110():201-7. PubMed ID: 23891829
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives.
Imai M; Shiota T; Kataoka K; Tarby CM; Moree WJ; Tsutsumi T; Sudo M; Ramirez-Weinhouse MM; Comer D; Sun CM; Yamagami S; Tanaka H; Morita T; Hada T; Greene J; Barnum D; Saunders J; Myers PL; Kato Y; Endo N
Bioorg Med Chem Lett; 2004 Nov; 14(21):5407-11. PubMed ID: 15454235
[TBL] [Abstract][Full Text] [Related]
20. Substituted benzylaminoalkylindoles with preference for the sigma2 binding site.
Mamolo MG; Zampieri D; Zanette C; Florio C; Collina S; Urbano M; Azzolina O; Vio L
Eur J Med Chem; 2008 Oct; 43(10):2073-81. PubMed ID: 18069094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
